Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart

Heart failure (HF) remains a major cause of morbidity and mortality worldwide. One of the risk factors for HF is cardiac hypertrophy (CH), which is frequently accompanied by cardiac fibrosis (CF). CH and CF are controlled by master regulators mTORC1 and TGF‐β, respectively. Type‐2‐phosphatidylinosit...

Descripción completa

Detalles Bibliográficos
Autores principales: Magadum, Ajit, Singh, Neha, Kurian, Ann Anu, Sharkar, Mohammad Tofael Kabir, Sultana, Nishat, Chepurko, Elena, Kaur, Keerat, Żak, Magdalena M., Hadas, Yoav, Lebeche, Djamel, Sahoo, Susmita, Hajjar, Roger, Zangi, Lior
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132051/
https://www.ncbi.nlm.nih.gov/pubmed/34026458
http://dx.doi.org/10.1002/advs.202004661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132051/
https://www.ncbi.nlm.nih.gov/pubmed/34026458
http://dx.doi.org/10.1002/advs.202004661

Ejemplares similares